Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Cancer Research|February 1, 1991
Phase I trial of natural human interferon beta in metastatic malignancyR M Bukowski, J S Sergi, W J Sharfman, et al.
American Journal of Clinical Oncology|June 11, 1999
Mature results from a phase II trial of accelerated induction chemoradiotherapy and surgery for poor prognosis stage III non-small-cell lung cancerD J Adelstein, T W Rice, L A Rybicki, et al.
Cancer Treatment Reports|December 1, 1986
Combined alkylators and multiple-site irradiation for extensive small cell lung cancer: a Southwest Oncology Group StudyR B Livingston, S Schulman, J G Mira, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1996
Immunomodulatory effects of interleukin-2 and interleukin-4 in patients with malignancyT Olencki, J Finke, R Tubbs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancerG T Budd, P C Adamson, M Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapyR M Bukowski, P Rayman, R Uzzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findingsR M Bukowski, T Olencki, H Gunn, et al.
The Annals of Thoracic Surgery|September 1, 1995
Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancerT W Rice, D J Adelstein, A Koka, et al.
Leukemia|September 30, 2005
Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706M A Hussein, H Gundacker, D R Head, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 1, 1997
Phase II trial of interleukin-2 and interferon-alpha in patients with renal cell carcinoma: clinical results and immunologic correlates of responseR M Bukowski, T Olencki, Q Wang, et al.
Pageof 10